Kura Oncology (KURA) Operating Leases: 2024-2025
Historic Operating Leases for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $8.4 million.
- Kura Oncology's Operating Leases rose 53.02% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 53.02%. This contributed to the annual value of $5.2 million for FY2024, which is N/A change from last year.
- As of Q3 2025, Kura Oncology's Operating Leases stood at $8.4 million, which was up 2.55% from $8.2 million recorded in Q2 2025.
- Kura Oncology's 5-year Operating Leases high stood at $8.4 million for Q3 2025, and its period low was $5.2 million during Q4 2024.
- In the last 2 years, Kura Oncology's Operating Leases had a median value of $6.2 million in 2024 and averaged $6.7 million.
- Data for Kura Oncology's Operating Leases shows a peak YoY surged of 53.02% (in 2025) over the last 5 years.
- Over the past 2 years, Kura Oncology's Operating Leases (Quarterly) stood at $5.2 million in 2024, then soared by 53.02% to $8.4 million in 2025.
- Its Operating Leases stands at $8.4 million for Q3 2025, versus $8.2 million for Q2 2025 and $7.9 million for Q1 2025.